The clinical significance of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma (HCC) is underscored by its high frequency of dysregulation and its profound impact on patient prognosis. The gene discussed is PIK3CA; the disease is hepatocellular carcinoma.